These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32171549)

  • 1. [Linear cutaneous hypopigmentation and atrophy associated with intralesional steroid injection for carpal tunnel syndrome].
    Bataille P; Monfort JB; Chasset F; De Risi-Pugliese T; Barbaud A; Senet P
    Ann Dermatol Venereol; 2020 Apr; 147(4):316-317. PubMed ID: 32171549
    [No Abstract]   [Full Text] [Related]  

  • 2. The efficacy of local steroid injections in idiopathic carpal tunnel syndrome: a double-blind study.
    Ozdoğan H; Yazici H
    Br J Rheumatol; 1984 Nov; 23(4):272-5. PubMed ID: 6487932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does fibromyalgia affect the outcomes of local steroid treatment in patients with carpal tunnel syndrome?
    Akkus S; Kutluhan S; Akhan G; Tunc E; Ozturk M; Koyuncuoglu HR
    Rheumatol Int; 2002 Jul; 22(3):112-5. PubMed ID: 12111086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conservative treatment of mild carpal tunnel syndrome. Infiltration of the carpal tunnel with crystalline corticoid suspension (Celestan Depot)].
    Manz F
    Nervenarzt; 1974 Jul; 45(7):387-8. PubMed ID: 4427697
    [No Abstract]   [Full Text] [Related]  

  • 5. Linear cutaneous hypopigmentation and atrophy associated with intralesional steroid injection: A rarely described adverse reaction.
    Magri F; Iacovino C; Vittori J; Pranteda G
    Dermatol Ther; 2019 Jul; 32(4):e12941. PubMed ID: 31012196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for using superpotent topical steroids.
    Prawer SE; Katz HI
    Am Fam Physician; 1990 May; 41(5):1531-8. PubMed ID: 2333829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of lidocaine and betamethasone dipropionate in carpal tunnel syndrome injection.
    Dernek B; Aydin T; Koseoglu PK; Kesiktas FN; Yesilyurt T; Diracoglu D; Aksoy C
    J Back Musculoskelet Rehabil; 2017; 30(3):435-440. PubMed ID: 28035909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional corticosteroid-induced hypopigmentation and atrophy.
    Weinhammer AP; Shields BE; Keenan T
    Dermatol Online J; 2020 Jan; 26(1):. PubMed ID: 32155037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid injections for tenosynovitis in the hand.
    Otto N; Wehbé MA
    Orthop Rev; 1986 May; 15(5):290-3. PubMed ID: 3453936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linear atrophy and hypopigmentation after intralesional corticosteroid injection.
    Hernández Aragüés I; Villanueva Álvarez-Santullano CA; Suárez Fernández R; Pulido Pérez A
    Reumatol Clin (Engl Ed); 2019; 15(5):e72-e73. PubMed ID: 29169871
    [No Abstract]   [Full Text] [Related]  

  • 11. Intracarpal steroid injection is safe and effective for short-term management of carpal tunnel syndrome.
    Armstrong T; Devor W; Borschel L; Contreras R
    Muscle Nerve; 2004 Jan; 29(1):82-8. PubMed ID: 14694502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study to assess the outcome of steroid injections and wrist splinting for the treatment of carpal tunnel syndrome.
    Graham RG; Hudson DA; Solomons M; Singer M
    Plast Reconstr Surg; 2004 Feb; 113(2):550-6. PubMed ID: 14758217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of perineural steroid injections on median nerve conduction during the carpal tunnel release.
    Stepić N; Novaković M; Martić V; Perić D
    Vojnosanit Pregl; 2008 Nov; 65(11):825-9. PubMed ID: 19069713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linear Atrophy and Cutaneous Hypopigmentation After an Intralesional Corticosteroid Injection: A Rare Adverse Effect.
    Porcar Saura S; Eixarch Dualde A; Pons Benavent M; Guillén Climent S
    Actas Dermosifiliogr; 2022; 113(10):1001-1002. PubMed ID: 35667387
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of Injection Volume on Rate of Subsequent Intervention in Carpal Tunnel Syndrome Over 1-Year Follow-Up.
    Evers S; Bryan AJ; Sanders TL; Gunderson T; Gelfman R; Amadio PC
    J Hand Surg Am; 2018 Jun; 43(6):537-544. PubMed ID: 29661547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional therapy in carpal tunnel syndrome: a sonographic-guided approach.
    Grassi W; Farina A; Filippucci E; Cervini C
    Clin Exp Rheumatol; 2002; 20(1):73-6. PubMed ID: 11892715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenosynovial injection for carpal tunnel syndrome.
    Minamikawa Y; Peimer CA; Kambe K; Wheeler DR; Sherwin FS
    J Hand Surg Am; 1992 Jan; 17(1):178-81. PubMed ID: 1538103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linear lymphatic hypopigmentation after intralesional corticosteroid injection: report of two cases.
    George WM
    Cutis; 1999 Jul; 64(1):61-4. PubMed ID: 10431677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound-guided insulin injection for carpal tunnel syndrome in type 2 diabetes mellitus patients.
    Kamel SR; Sadek HA; Hamed A; Sayed OA; Mahmud MH; Mohamed FA; El Sagher GM; Aly LH
    Clin Rheumatol; 2019 Oct; 38(10):2933-2940. PubMed ID: 31209710
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.